PolyPid (PYPD) director Dror-Darwish Nir lists six vested option grants

Rhea-AI Filing Summary

PolyPid Ltd. director Dror-Darwish Nir reported existing option holdings in a Form 3. The filing lists six stock option grants over Ordinary Shares, with exercise prices ranging from 2.6700 to 23.0700 and expiration dates between 2030 and 2036. Footnotes state that most grants are already fully vested, while one grant made on June 25, 2025 vests quarterly through May 12, 2029.

Insider Trade Summary

6 transactions reported

Mixed 6 txns

Insider Dror-Darwish Nir

Role Director

Type	Security	Shares	Price	Value
holding	Stock option (right to buy)	--	--	--
holding	Stock option (right to buy)	--	--	--
holding	Stock option (right to buy)	--	--	--
holding	Stock option (right to buy)	--	--	--
holding	Stock option (right to buy)	--	--	--
holding	Stock option (right to buy)	--	--	--

Holdings After Transaction: Stock option (right to buy) — 312 shares (Direct)

Footnotes (1)

1. The options were granted on May 5, 2023 and fully vested as of May 5, 2024. The options were granted on June 18, 2020 and fully vested as of June 4, 2023. The options were granted on April 13, 2021 and fully vested as of April 13, 2022. The options were granted on May 3, 2022 and fully vested as of May 3, 2023. The options were granted on July 2, 2024 and fully vested as of July 2, 2025. The options were granted on June 25, 2025 and vest on a quarterly basis beginning May 12, 2025 until May 12, 2029.

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Dror-Darwish Nir

(Last) (First) (Middle)

C/O POLYPID LTD.

18 HASIVIM STREET ISRAEL

(Street)

PETACH TIKVA 495376

(City) (State) (Zip)

ISRAEL

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
PolyPid Ltd. [ PYPD ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock option (right to buy)	08/05/2023	05/05/2033	Ordinary Shares	312(1)	$11.4	D
Stock option (right to buy)	06/04/2021	06/18/2030	Ordinary Shares	597(2)	$23.07	D
Stock option (right to buy)	07/13/2021	04/13/2031	Ordinary Shares	299(3)	$23.07	D
Stock option (right to buy)	08/03/2022	05/03/2032	Ordinary Shares	312(4)	$23.07	D
Stock option (right to buy)	10/02/2024	07/02/2034	Ordinary Shares	6,500(5)	$4.24	D
Stock option (right to buy)	08/12/2025	06/25/2036	Ordinary Shares	14,440(6)	$2.67	D

Explanation of Responses:

1. The options were granted on May 5, 2023 and fully vested as of May 5, 2024.

2. The options were granted on June 18, 2020 and fully vested as of June 4, 2023.

3. The options were granted on April 13, 2021 and fully vested as of April 13, 2022.

4. The options were granted on May 3, 2022 and fully vested as of May 3, 2023.

5. The options were granted on July 2, 2024 and fully vested as of July 2, 2025.

6. The options were granted on June 25, 2025 and vest on a quarterly basis beginning May 12, 2025 until May 12, 2029.

	/s/ Nir Dror	03/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the PolyPid (PYPD) Form 3 filing by Dror-Darwish Nir show?

The Form 3 filing shows Dror-Darwish Nir’s existing stock option holdings in PolyPid. It lists six option grants over Ordinary Shares, detailing exercise prices, expiration dates, and vesting schedules, rather than reporting any new share purchases or sales.

How many stock option grants are reported for Dror-Darwish Nir at PolyPid (PYPD)?

The filing reports six separate stock option grants held by Dror-Darwish Nir. Each grant covers Ordinary Shares with specified exercise prices, exercise dates, and expiration dates, giving a clear view of his current option-based exposure to PolyPid shares.

What are the exercise price ranges of Dror-Darwish Nir’s PolyPid (PYPD) options?

The reported options have exercise prices ranging from 2.6700 to 23.0700 per Ordinary Share. These prices reflect the cost at which he can purchase shares under each grant, if he chooses to exercise the options before they expire.

When do Dror-Darwish Nir’s PolyPid (PYPD) stock options expire?

The options have expiration dates between 2030 and 2036, depending on the specific grant. This long-dated schedule means he retains the right to buy PolyPid Ordinary Shares under these options for many years, subject to each grant’s terms.

Are Dror-Darwish Nir’s PolyPid (PYPD) options vested according to the Form 3?

Most reported option grants are fully vested, as stated in the footnotes with vesting completion dates from 2022 to 2025. One grant from June 25, 2025 vests quarterly beginning May 12, 2025 and continues until May 12, 2029.

Does the PolyPid (PYPD) Form 3 for Dror-Darwish Nir show any share purchases or sales?

The Form 3 does not show new purchases or sales of shares. Instead, it records existing stock option holdings and their terms, including underlying Ordinary Shares, exercise prices, vesting status, and expiration dates as of the reporting date.